Open Access iconOpen Access

ARTICLE

crossmark

Thioredoxin domain-containing protein 9 protects cells against UV-B-provoked apoptosis via NF-κB/p65 activation in cutaneous squamous cell carcinoma

by ZHIXUN XIAO1, QIUYUN XU1, HAIQING WANG1, XIAOTONG ZHOU2, YANTING ZHU1, CHENGBEI BAO1, LIHONG CHEN1, PENG ZHANG1, MIN LIN1, CHAO JI1,*, TING GONG3,*

1 Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China
2 Cancer Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China
3 Central Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China

* Corresponding Authors: Chao Ji, email; Ting Gong, email

Oncology Research 2023, 31(1), 71-82. https://doi.org/10.32604/or.2022.028075

Abstract

Cutaneous squamous cell carcinoma (cSCC), a type of non-melanoma skin cancer (NMSC), is the most common malignancy worldwide. Thioredoxin (TXN) domain-containing protein 9 (TXNDC9) is a member of the TXN family that is important in cell differentiation. However, the biological function of this protein in cancer, particularly cSCC, is still unknown. In the present study, our experiments revealed the protective effects of TXNDC9 on UV-B-irritated cSCC cells. The initial findings showed that TXNDC9 is significantly upregulated in cSCC tissue and cells compared to normal skin tissue and keratinocytes. UV-B radiation robustly induces the expression of TXNDC9, and UV-B-induced cSCC cell death is boosted by TXNDC9 deficiency. Moreover, cSCC cells lacking TXNDC9 displayed attenuated activation of the NF-κB pathway. Additional studies by inhibiting TXNDC9 confirmed this finding, as TXNDC9 deficiency attenuated UV-B radiation-induced translocation of NF-κB p65 from the cytoplasm to the nucleus of cSCC. In conclusion, our work demonstrates the biological roles of TXNDC9 in cSCC progression and may provide a novel therapeutic target to treat cSCC in the future.

Keywords


Cite This Article

APA Style
XIAO, Z., XU, Q., WANG, H., ZHOU, X., ZHU, Y. et al. (2023). Thioredoxin domain-containing protein 9 protects cells against uv-b-provoked apoptosis via nf-κb/p65 activation in cutaneous squamous cell carcinoma. Oncology Research, 31(1), 71-82. https://doi.org/10.32604/or.2022.028075
Vancouver Style
XIAO Z, XU Q, WANG H, ZHOU X, ZHU Y, BAO C, et al. Thioredoxin domain-containing protein 9 protects cells against uv-b-provoked apoptosis via nf-κb/p65 activation in cutaneous squamous cell carcinoma. Oncol Res. 2023;31(1):71-82 https://doi.org/10.32604/or.2022.028075
IEEE Style
Z. XIAO et al., “Thioredoxin domain-containing protein 9 protects cells against UV-B-provoked apoptosis via NF-κB/p65 activation in cutaneous squamous cell carcinoma,” Oncol. Res., vol. 31, no. 1, pp. 71-82, 2023. https://doi.org/10.32604/or.2022.028075



cc Copyright © 2023 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1529

    View

  • 715

    Download

  • 0

    Like

Share Link